Additionally, as previously announced, suzetrigine is under FDA review for the treatment of moderate-to-severe acute pain ... Phase 2 Suzetrigine Lumbosacral Radiculopathy (LSR) Study This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback